Maintain qualified network of 22 warehouse hubs and depots distributing clinical trial material to 67 countries and 12,000 investigators. Increased distribution performance by >75% to achieve greater than 99.8% Perfect Shipments (right products, right location, right time, and Fit-for-Use) in support of 350 clinical trials and approximatley 50,000 annual shipments. Qualified and implemented suite of 4 cold chain shippers reducing costs by $1.8 million annually and addressing quality, ergonomic, and environmental issues. Project has won 4 prestigious Lilly awards including: Supplier of the Year, 2 environmental awards, and Lilly Top 100 Innovator.Reduced material temperature excursions by 65% via strong courier relationships, tighter integration, and managed hand-offs.Developed and implementing Controlled Room Temperature material strategy to address changing regulatory requirements and behaviors.Drove Out-of-Drug Calls for clinical trial materials to industry leading levels working across supply planning, manufacturing, packaging and distribution.Successfully started new Clinical Trial Ancillary supply group, Temperature Excursion Call Center, and Distribution Center of Excellence in response to growing business trends and to meet customer needs.Managing >$50 million in spend - reduced costs by 9% by initiating multiple 6-sigma project and leveraging various supplier and partner relationships.

Expanded and improved Lilly's capabilities to predict and influence the speed of which Clinical Trials are enrolled shaving valuable time off the critical path to submission of new products.Enhanced accuracy of trial enrollment predications by greater than 42% which enabled more efficient use of resources and better informed decision making. Avoided the start of numerous "futile" trials based on solid industry wide validated CT data saving the company millions in avoided expenses.Identified Pediatric Clinical Trial trend and pulled together cross disciplinary group in first every Lilly Pediatric Conference to Design and Enroll trials in an accelerated fashion. Developed team of consultants that evaluated every Lilly protocol predicting enrollment rates and offering design changes that would accelerate enrollment.Identified immerging CT Enrollment companies and connected them with internal trials to enhance enrollment. Successfully demonstrated strong business cases to justify multi-million dollar investments to accelerate enrollment on clinical trials. Reduced enrollment by weeks, months and over a year on multiple diabetes, biomedicine, and oncology products that are now being submitted or launched ahead of schedule driving strong market enthusiasm. Created numerous entrepreneurial partnerships and ran nearly a dozen pilot programs enabling Lilly to find several new ways of enhancing Clinical Trial enrollment. Developed suite of Patient Centric Clinical Trial Enrollment enhancers which we installed on every clinical trial. Developed a decision tree for which tool worked best based on therapeutic area, and trial designs which was further optimized by trial enrollment results. Developed a first every Lilly Social Media policy for clinical trial enrollment challenging and balancing Lilly and big pharma conservative tendencies in this area which was eventually approved by the most senior levels within Lilly.

Six Sigam is Eli Lilly's chosen methodology for improving productivity and eliminating waste. The Black Belt positions are considered key leadership development positions and individuals selected must have senior leadership potential.Successfully completed 6 week intensive training and became certified 6-sigma black belt after completing required 2 projects. During my 6-sigma assignment I completed 5 major projects. Lead projects across Lilly including Corporate Security, Clinical Diagnostic Services, Clinical Research, Sourcing, and Procurement. Projects had a documented $15 million in cost reductions annually while reducing cycle times, making Lilly more efficient by avoiding the need to add headcount and eliminating non value added work. Additionally, since leaving this assignment I have now completed 6-sigma stakeholder and sponsor training, sponsored 12 projects and participated as a stakeholder on 7 projects.

Responsible for managing all Laboratory, ECG, and Imaging services required in support of phase I - IV clincial trials. Managed dozens of vendors, 30 to 50 new contracts each year, and $20 to $30 million dollars in annual spend.